For example, multiple IL-23 inhibitors demonstrated high efficacy and safety for treating plaque psoriasis, thereby highlighting the importance of cells producing IL-23, specifically myeloid cells (i.e., macrophages, monocytes, and dendritic cells) (4–6). The gene discussed is IL23A; the disease is psoriasis vulgaris.